The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kanes Stephen since 2014.
The trader's CIK number is 1612859.
At the time of the last reporting, Kanes Stephen was the Chief Medical Officer of Sage Therapeutics, Inc.. (stock ticker symbol SAGE).
Also see all insider trading activities at Sage Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | SAGE | 0 | $0 | 22,948 | $3,442,200 | 6,000 | $2,700 |
| 2018 | SAGE | 0 | $0 | 44,000 | $7,730,799 | 20,000 | $9,000 |
| 2016 | SAGE | 0 | $0 | 21,000 | $798,000 | 21,000 | $9,450 |
| 2015 | SAGE | 0 | $0 | 46,336 | $2,462,852 | 28,936 | $13,021 |
| 2014 | SAGE | 3,000 | $54,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-04 | SAGE | Option Ex | 6,000 | .45 | 2,700 |
| 2019-02-08 | SAGE | Sale | 22,948 | 150.00 | 3,442,200 |
| 2018-01-10 | SAGE | Sale | 44,000 | 175.70 | 7,730,799 |
| 2018-01-12 | SAGE | Option Ex | 20,000 | .45 | 9,000 |
| 2016-04-20 | SAGE | Option Ex | 21,000 | .45 | 9,450 |
| 2016-04-19 | SAGE | Sale | 21,000 | 38.00 | 798,000 |
| 2015-09-28 | SAGE | Sale | 6,000 | 46.42 | 278,520 |
| 2015-09-28 | SAGE | Option Ex | 21,000 | .45 | 9,450 |
| 2015-08-31 | SAGE | Sale | 12,000 | 53.12 | 637,440 |
| 2015-07-27 | SAGE | Option Ex | 1,936 | .45 | 871 |
| 2015-07-27 | SAGE | Sale | 4,936 | 70.60 | 348,471 |
| 2015-06-24 | SAGE | Option Ex | 6,000 | .45 | 2,700 |
| 2015-06-24 | SAGE | Sale | 6,000 | 74.06 | 444,360 |
| 2015-03-25 | SAGE | Sale | 5,400 | 51.49 | 278,046 |
| 2015-02-25 | SAGE | Sale | 6,000 | 42.05 | 252,299 |
| 2015-01-26 | SAGE | Sale | 6,000 | 37.29 | 223,716 |
| 2014-07-23 | SAGE | Buy | 3,000 | 18.00 | 54,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kanes Stephen (Chief Medical Officer of Sage Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.